Sutro Biopharma Funding & Investors
South San Francisco, CA
Sutro Biopharma, Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Sutro Biopharma serves the pharmaceutical industries throughout the United States.
sutrobio.comTotal Amount Raised: $636,604,992
Sutro Biopharma Funding Rounds
Post Ipo Equity
$75,000,000
Post Ipo Debt
$140,000,000
Post Ipo Debt Investors
Blackstone Life SciencesPost Ipo Equity
$144,900,000
Post Ipo Equity Investors
Frazier ManagementPost Ipo Equity
$75,000,000
Series E
$85,400,000
Series E Investors
Samsara BioCapitalSurveyor CapitalEventideAmgenNexthera CapitalSV Health InvestorsCelgeneLilly VenturesSkyline VenturesTekla Capital ManagementVida VenturesMerckAlta PartnersCitadelCenteneIPO
Unknown
Series D
$26,000,000
Series D Investors
Alta PartnersSV Health InvestorsSkyline VenturesEli LillyCelgeneAmgenSeries C
$16,500,000
Series C Investors
SV Health InvestorsSkyline VenturesAmgenLilly VenturesAlta PartnersSeries C
$36,500,000
Series C Investors
Skyline VenturesAmgenLilly VenturesSV Health InvestorsAlta PartnersSeries B
$15,000,000
Series B Investors
Alta PartnersSV Health InvestorsSeries B
$21,000,000
Series B Investors
SV Health InvestorsAlta PartnersSeries Unknown
$305,000
Series Unknown Investors
International Biotechnology TrustSV Health InvestorsSeries A
$1,000,000
Series A Investors
SV Health Investors
Funding info provided by Diffbot.